Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Aztec Sweet Herb (Lippia dulcis) contains hernandulcin, a sesquiterpene glycoside that provides sweetness approximately 1,000 times greater than sucrose without affecting blood glucose levels. The herb's bioactive compounds, including flavonoids and polyphenols, demonstrate anti-inflammatory and antioxidant mechanisms that support respiratory and immune function.
Reported Benefits (Provisional)
Origin & History
Aztec Sweet Herb (Lippia dulcis), also known as honey herb or yerba dulce, is a perennial herb native to Central America, including Mexico and the Caribbean. Its intensely sweet leaves contain hernandulcin, a compound over 1,000 times sweeter than sugar. This botanical is valued as a natural, zero-glycemic sweetener and for its traditional medicinal applications.
Research Narrative (Provisional)
Research, including in vitro and preliminary animal studies, validates Aztec Sweet Herb's zero-glycemic sweetening properties due to hernandulcin, alongside its antioxidant, anti-inflammatory, and respiratory benefits. These studies support its traditional uses and highlight its potential as a natural sweetener and therapeutic botanical.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Sweeteners: Hernandulcin (intense natural sweetness, zero glycemic impact). - Phytochemicals: Flavonoids, polyphenols (antioxidant, anti-inflammatory, immune support), saponins (cholesterol regulation). - Vitamins: Vitamin B6 (cognitive function, energy metabolism). - Minerals: Magnesium, potassium, calcium, iron (muscle function, bone health, blood pressure regulation). - Dietary Fiber: Supports digestive health.
Reported Mechanism (Provisional)
Hernandulcin, the primary sesquiterpene glycoside, activates sweet taste receptors without triggering insulin release or glucose metabolism pathways. The herb's flavonoids and polyphenols modulate inflammatory cascades by inhibiting pro-inflammatory cytokines and enhancing antioxidant enzyme activity. Anti-inflammatory compounds appear to reduce respiratory tract inflammation through cyclooxygenase and lipoxygenase pathway inhibition.
Clinical Narrative (Provisional)
Current evidence consists primarily of in vitro studies and preliminary animal research validating hernandulcin's zero-glycemic sweetening properties and antioxidant activity. No large-scale human clinical trials have been conducted to establish therapeutic dosages or quantify clinical outcomes. The existing research supports traditional uses but lacks rigorous clinical validation with specific patient populations. Evidence strength remains limited to preclinical studies and traditional use documentation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.